Atopaxar Hydrobromide

• Target :

  Protease-activated Receptor|||Apoptosis|||JAK

• Related Pathways :

  Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||GPCR/G Protein|||Stem Cells|||Angiogenesis|||JAK/STAT signaling|||Apoptosis

• Purity :

  >99.99%

• Bioactivity :

  Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.

• Smiles :

  Br.CCOc1cc2CN(CC(=O)c3cc(N4CCOCC4)c(OC)c(c3)C(C)(C)C)C(=N)c2c(F)c1OCC

• Molecular Formula :

  C29H39BrFN3O5

• Molecular Weight :

  608.54

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  474550-69-1